IShares Nasdaq Biotechnology ETF Profit Margin 1970-1969 | IBB
Current and historical gross margin, operating margin and net profit margin for IShares Nasdaq Biotechnology ETF (IBB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. IShares Nasdaq Biotechnology ETF net profit margin as of December 31, 1969 is 0%.
|IShares Nasdaq Biotechnology ETF Annual Profit Margins
|IShares Nasdaq Biotechnology ETF Quarterly Profit Margins
||Finance - Publicly Traded Investment Trusts
The ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.